ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,586.55
      -0.50%
      US Tech 100
      18,835.60
      -0.39%
      Dow Jones
      41,484.81
      -1.02%
      Brent Oil
      69.825
      1.14%
      Bitcoin
      80,737.85
      2.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Novo Nordisk (NVO)

      7. Novo Nordisk (NVO) Financials

      Novo Nordisk

      Novo Nordisk (NVO)

      Novo Resources Corp
      Novo Resources Corp
      Novo Resources Corp
      77.77
      -1.18
      ( -1.49% )
      Updated: 10:57:07
      Delayed by 15 minutes

      Novo Nordisk Financial Summary

      The current NVO market cap is 347.24B. The company's latest EPS is DKK 22.6177 and P/E is 3.50.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 65.86B65.35B68.06B71.31B85.68B
      Operating Income 26.85B31.85B25.93B33.82B36.72B
      Net Income 21.96B25.41B20.05B27.3B28.23B
      Year End December 30 2024 20202021202220232024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 126.95B140.8B176.95B232.26B290.4B
      Operating Income 54.28B58.62B74.62B102.66B128.32B
      Net Income 42.14B47.76B55.53B83.68B100.99B

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 314.49B298.92B369.38B397.44B465.8B
      Total Liabilities 207.93B200.01B256.86B276.92B322.31B
      Total Equity 106.56B98.91B112.52B120.52B143.49B
      Year End December 30 2024 20202021202220232024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 144.92B194.51B241.26B314.49B465.8B
      Total Liabilities 81.6B123.76B157.77B207.93B322.31B
      Total Equity 63.33B70.75B83.49B106.56B143.49B

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 108.91B14.31B64.82B108.67B120.97B
      Investing -43.89B3.96B-16.78B-37.68B-128.9B
      Financing -63.16B-26.38B-9.7B-28.1B8.74B
      Year End December 30 2024 20202021202220232024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 51.95B55B78.89B108.91B120.97B
      Investing -22.44B-31.61B-24.92B-43.89B-128.9B
      Financing -32.24B-25.49B-51.8B-63.16B8.74B

      Stats and Ratios

      Market Cap 347.24B
      Price to Earnings Ratio 3.50
      Price to Sales Ratio 1.22
      Price to Cash Ratio 22.6
      Price to Book Ratio 2.47
      Dividend Yield 2.07%

      Share Statistics

      Shares Outstanding 4.47B
      Average Volume (1 week) 7.29M
      Average Volume (1 Month) 7.92M
      52 Week Change -41.69%
      52 Week High 148.15
      52 Week Low 77.52
      Spread (Intraday) 0.02 (0.03%)

      Company Info

      Company Name Novo Nordisk
      Address novo alle
      bagsvaerd DK-2880
      Website https://www.novonordisk.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NYSE
      NVO
      Novo Nordisk
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads